ACELRX PHARMACEUTICALS INC filings

SEC filings by ACELRX PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14ARMISTICE CAPITAL, LLCTALPHERA, INC.890,3465.0%EDGAR
SC 13G/A2024-02-13Lind Global Fund II LPTALPHERA, INC.735,296-EDGAR
SC 13D2024-01-23Nantahala Capital Management, LLCTALPHERA, INC.1,992,51911.8%EDGAR
SC 13G2023-08-01Lind Global Fund II LPACELRX PHARMACEUTICALS INC1,102,944-EDGAR
SC 13G/A2023-02-14ARMISTICE CAPITAL, LLCACELRX PHARMACEUTICALS INC864,32810.0%EDGAR
SC 13G2022-02-15ARMISTICE CAPITAL, LLCACELRX PHARMACEUTICALS INC12,314,47910.0%EDGAR
SC 13G/A2022-01-27BML Investment Partners, L.P.ACELRX PHARMACEUTICALS INC00.0%EDGAR
SC 13G/A2021-07-12BlackRock Inc.ACELRX PHARMACEUTICALS INC2,266,0401.9%EDGAR
SC 13G/A2021-02-10BML Investment Partners, L.P.ACELRX PHARMACEUTICALS INC5,200,0005.3%EDGAR
SC 13G/A2021-01-29BlackRock Inc.ACELRX PHARMACEUTICALS INC5,640,9465.7%EDGAR
SC 13G2020-10-27BML Investment Partners, L.P.ACELRX PHARMACEUTICALS INC4,064,8034.5%EDGAR
SC 13G2020-10-27BML Investment Partners, L.P.ACELRX PHARMACEUTICALS INC4,064,8034.5%EDGAR
SC 13G2020-02-07BlackRock Inc.ACELRX PHARMACEUTICALS INC5,612,0177.1%EDGAR
SC 13G2018-05-31Industry Ventures Secondary VIII, L.P.ACELRX PHARMACEUTICALS INC3,746,8177.3%EDGAR
SC 13G2018-05-31LEERINK REVELATION HEALTHCARE FUND I, L.P.ACELRX PHARMACEUTICALS INC3,746,8177.3%EDGAR
SC 13D/A2018-05-24THREE ARCH PARTNERS IV LPACELRX PHARMACEUTICALS INC00.0%EDGAR
SC 13D/A2018-02-14THREE ARCH PARTNERS IV LPACELRX PHARMACEUTICALS INC5,713,56911.3%EDGAR
SC 13G/A2017-08-23PERCEPTIVE ADVISORS LLCACELRX PHARMACEUTICALS INC1,244,6082.7%EDGAR
SC 13D/A2017-02-15THREE ARCH PARTNERS IV LPACELRX PHARMACEUTICALS INC5,901,58913.0%EDGAR
SC 13G/A2017-02-14PERCEPTIVE ADVISORS LLCACELRX PHARMACEUTICALS INC5,408,72811.9%EDGAR